Advarra reposted this
Passionate about collaboration, change management, and improving processes in Clinical Research to improve our industry! ACRP Fellow & 2023 Chair of the Board.
Some thoughts about pain points in #clinicalresearch and how to fix them: ▶ Streamline the contract and budget process ▶ Embrace digitalization while battling data silos ▶ Revolutionize #patientrecruitment There are more pain points, and I'd love to hear your thoughts on these or others!
John Neal
2w
Amen to all your points Christine! While the current industry standard may be a month or longer at independent sites, and nine months at AMCs, we consistently complete the entire negotiation in less than a week, and in most cases as little as an hour. Obviously not typical, but we implemented Master CTAs and Budgets years ago with those sponsors willing to do so. Of course, some won’t, so those negotiations take longer (usually less than two weeks.) We still run into “silo” issues, but those are always resolved quickly. Sometimes the solution is simply to ask. The answer won’t always be yes, but in those cases where the sponsor agrees, everyone wins.
Love the article, especially when it comes to patient recruitment. Agree that Sponsors, IRBs, and Sites need to leverage modern marketing techniques. A one-size-fits-all digital campaign is not enough, and the entire patient recruitment experience should be considered in the context of a marketing funnel. As an experienced marketing pro working on the site level, I'd love to see a fully fleshed out marketing plan for patient recruitment from a sponsor that accounts for earned, owned, and paid media. Christine Senn, PhD, thank you for sharing your thoughts and Advarra's ambitions!
We have to address placing studies in the appropriate setting for recruitment, operational, and clinical success (e.g., independent units for broad criteria studies, embedded sites for potentially therapeutic clinical trials, etc.).
Priya Sagar
2w
Some great insights
Over two decades in life sciences with emphasis and education in healthcare economics, regulatory, commercialization, advisory and consulting. From start up to fortune 10 medical device and pharmaceutical companies.
2wVery well articulated. I was asked to lend my thoughts to the Health and Public Policy Director for the U.S. House of Representatives last Thursday on some of these points. My main focus in my latest adventure, has been creating a pricing deliverable that can be completely budgeted and shares, or takes a majority of the risk in patient recruitment. On avg., patient recruitment accounts for 31% of the overall trial budget. I believe I have solved this. This has been a massive problem for many CRO's and Sponsor's and I believe we may have produced / deployed a solution that innovates the entire market. This all begins with the ability to simulate, with accuracy - race, ethnicity, sex, age, and consents / randomizations, before the trial even starts. This requires capabilities that most patient recruitment companies don't have. This also satisfies the new legislative movement in Diversity Action Plans (DAP's). An ad agency approach to patient recruitment is still needed, but antiquated in modeling / approach. Great article and glad to see many others in the industry focusing on tackling some of these problems.